Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: A4I5N2
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0140575 | transmembrane monodehydroascorbate reductase activity | 3 | 11 |
GO:0005488 | binding | 1 | 1 |
GO:0020037 | heme binding | 4 | 1 |
GO:0046906 | tetrapyrrole binding | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.252 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.410 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.339 |
CLV_PCSK_FUR_1 | 20 | 24 | PF00082 | 0.245 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.346 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.251 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.356 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.346 |
CLV_PCSK_PC7_1 | 74 | 80 | PF00082 | 0.251 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.382 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.556 |
DEG_SPOP_SBC_1 | 7 | 11 | PF00917 | 0.553 |
DOC_ANK_TNKS_1 | 22 | 29 | PF00023 | 0.433 |
DOC_CYCLIN_yCln2_LP_2 | 153 | 159 | PF00134 | 0.387 |
DOC_MAPK_gen_1 | 20 | 29 | PF00069 | 0.528 |
DOC_MAPK_MEF2A_6 | 22 | 31 | PF00069 | 0.515 |
DOC_PP1_SILK_1 | 147 | 152 | PF00149 | 0.292 |
DOC_PP2B_LxvP_1 | 153 | 156 | PF13499 | 0.387 |
DOC_PP4_MxPP_1 | 196 | 199 | PF00568 | 0.250 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.470 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.705 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.609 |
LIG_Actin_WH2_2 | 60 | 76 | PF00022 | 0.344 |
LIG_EH1_1 | 50 | 58 | PF00400 | 0.279 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.374 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.455 |
LIG_LIR_Gen_1 | 114 | 123 | PF02991 | 0.270 |
LIG_LIR_Nem_3 | 114 | 118 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 134 | 138 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 4 | 8 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 41 | 47 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 49 | 53 | PF02991 | 0.232 |
LIG_LYPXL_yS_3 | 122 | 125 | PF13949 | 0.251 |
LIG_LYPXL_yS_3 | 5 | 8 | PF13949 | 0.549 |
LIG_MYND_2 | 198 | 202 | PF01753 | 0.205 |
LIG_NRBOX | 149 | 155 | PF00104 | 0.283 |
LIG_SH2_CRK | 115 | 119 | PF00017 | 0.372 |
LIG_SH2_CRK | 44 | 48 | PF00017 | 0.314 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.239 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.380 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.435 |
LIG_SH3_2 | 156 | 161 | PF14604 | 0.488 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.473 |
LIG_SH3_3 | 28 | 34 | PF00018 | 0.408 |
LIG_SUMO_SIM_par_1 | 172 | 178 | PF11976 | 0.295 |
LIG_TRFH_1 | 152 | 156 | PF08558 | 0.533 |
LIG_TYR_ITIM | 113 | 118 | PF00017 | 0.288 |
LIG_WRC_WIRS_1 | 132 | 137 | PF05994 | 0.201 |
LIG_WRC_WIRS_1 | 97 | 102 | PF05994 | 0.344 |
LIG_WW_3 | 11 | 15 | PF00397 | 0.528 |
LIG_WW_3 | 85 | 89 | PF00397 | 0.387 |
MOD_CDC14_SPxK_1 | 11 | 14 | PF00782 | 0.560 |
MOD_CDK_SPxK_1 | 8 | 14 | PF00069 | 0.579 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.187 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.519 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.282 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.562 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.324 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.310 |
MOD_GSK3_1 | 197 | 204 | PF00069 | 0.288 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.473 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.557 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.371 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.470 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.646 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.484 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.204 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.187 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.325 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.259 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.296 |
MOD_Plk_4 | 96 | 102 | PF00069 | 0.528 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.470 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.703 |
MOD_SUMO_rev_2 | 65 | 73 | PF00179 | 0.292 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.288 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.549 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.237 |
TRG_ER_diArg_1 | 20 | 23 | PF00400 | 0.509 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JNM4 | Bodo saltans | 25% | 92% |
A0A1X0P2F3 | Trypanosomatidae | 25% | 89% |
A0A3Q8IC17 | Leishmania donovani | 99% | 100% |
A0A3R7RSY6 | Trypanosoma rangeli | 30% | 91% |
A4HID6 | Leishmania braziliensis | 66% | 100% |
C9ZR03 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 21% | 92% |
E9B0X7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4Q789 | Leishmania major | 84% | 100% |
V5BPF8 | Trypanosoma cruzi | 26% | 92% |